178 related articles for article (PubMed ID: 29619858)
1. Influence of serous retinal detachment on the outcome of ranibizumab treatment in diabetic macular oedema.
Ercalik NY; Imamoglu S; Turkseven Kumral E; Yenerel NM; Bardak H; Bardak Y
Cutan Ocul Toxicol; 2018 Dec; 37(4):324-327. PubMed ID: 29619858
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effect of ranibizumab and dexamethasone implant on serous retinal detachment in diabetic macular edema.
Demircan A; Ozkaya A; Alkin Z; Kemer B; Yesilkaya C; Demir G
J Fr Ophtalmol; 2018 Oct; 41(8):733-738. PubMed ID: 30213609
[TBL] [Abstract][Full Text] [Related]
4. Functional and Anatomical Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab.
Giocanti-Aurégan A; Hrarat L; Qu LM; Sarda V; Boubaya M; Levy V; Chaine G; Fajnkuchen F
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):797-800. PubMed ID: 28152140
[TBL] [Abstract][Full Text] [Related]
5. A Comparison Study of Ranibizumab and Aflibercept in Patients with Naive Diabetic Macular Edema in Presence of Serous Retinal Detachment.
Kaldırım H; Yazgan S; Kırgız A; Atalay K; Savur F
Curr Eye Res; 2019 Sep; 44(9):987-993. PubMed ID: 30983426
[No Abstract] [Full Text] [Related]
6. Combined Intravitreal Ranibizumab and Sub-Tenon Injection of Triamcinolone for the Treatment of Diabetic Macular Edema with Retinal Detachment.
Ercalik NY; Yenerel NM; Imamoglu S; Kumral ET; Vural ET
J Ocul Pharmacol Ther; 2016 May; 32(4):225-9. PubMed ID: 27092435
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography biomarkers DROL, PROS, SND, hyperreflective walls of foveal cystoid spaces as predictors of central macular thickness and visual acuity in diabetic macular edema treated with intravitreal ranibizumab.
Sardana A; Singh K; Singh A; Singh VK
Indian J Ophthalmol; 2024 May; 72(5):722-727. PubMed ID: 38648434
[TBL] [Abstract][Full Text] [Related]
8. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intravitreal ranibizumab, aflibercept and bevacizumab therapies in diabetic macular edema with serous retinal detachment.
Sirakaya E; Kilic D; Aslan Sirakaya H
Eur J Ophthalmol; 2023 May; 33(3):1459-1466. PubMed ID: 36482707
[TBL] [Abstract][Full Text] [Related]
10. Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema.
Mori Y; Murakami T; Suzuma K; Ishihara K; Yoshitake S; Fujimoto M; Dodo Y; Yoshitake T; Miwa Y; Tsujikawa A
PLoS One; 2017; 12(4):e0175809. PubMed ID: 28407012
[TBL] [Abstract][Full Text] [Related]
11. Anatomical and functional responses in eyes with diabetic macular edema treated with "1 + PRN" ranibizumab: one-year outcomes in population of mainland China.
Lai K; Huang C; Li L; Gong Y; Xu F; Zhong X; Lu L; Jin C
BMC Ophthalmol; 2020 Jun; 20(1):229. PubMed ID: 32539744
[TBL] [Abstract][Full Text] [Related]
12. VISUAL AND MORPHOLOGIC OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR DIABETIC MACULAR EDEMA BASED ON OPTICAL COHERENCE TOMOGRAPHY PATTERNS.
Seo KH; Yu SY; Kim M; Kwak HW
Retina; 2016 Mar; 36(3):588-95. PubMed ID: 26398695
[TBL] [Abstract][Full Text] [Related]
13. Diabetic macular oedema treated with intravitreal anti-vascular endothelial growth factor - 2-4 years follow-up of visual acuity and retinal thickness in 566 patients following Danish national guidelines.
Hodzic-Hadzibegovic D; Sander BA; Monberg TJ; Larsen M; Lund-Andersen H
Acta Ophthalmol; 2018 May; 96(3):267-278. PubMed ID: 29240306
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone implant as an adjuvant therapy to ranibizumab loading dose in persistent diabetic macular edema.
Cakir A; Erden B; Bolukbasi S; Bayat AH; Ozturan SG; Elcioglu MN
Int Ophthalmol; 2019 Oct; 39(10):2179-2185. PubMed ID: 30470985
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical outcomes of different components of diabetic macular edema on optical coherence tomography.
Hu Y; Wu Q; Liu B; Cao D; Dong X; Zhang L; Li T; Yang X; Yu H
Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2613-2621. PubMed ID: 31529324
[TBL] [Abstract][Full Text] [Related]
16. Subfoveal choroidal thickness changes after intravitreal ranibizumab injections in different patterns of diabetic macular edema using a deep learning-based auto-segmentation.
Wang XN; Cai X; He S; Zhang X; Wu Q
Int Ophthalmol; 2023 Dec; 43(12):4399-4407. PubMed ID: 33783677
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes.
Laugesen CS; Ostri C; Brynskov T; Lund-Andersen H; Larsen M; Vorum H; Sørensen TL
Acta Ophthalmol; 2017 Feb; 95(1):28-32. PubMed ID: 27473397
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.
Kim M; Lee P; Kim Y; Yu SY; Kwak HW
Ophthalmologica; 2011; 226(3):138-44. PubMed ID: 21822008
[TBL] [Abstract][Full Text] [Related]
19. Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumab.
Baget-Bernaldiz M; Romero-Aroca P; Bautista-Perez A; Mercado J
Doc Ophthalmol; 2017 Oct; 135(2):85-96. PubMed ID: 28779336
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the short-term effect of aflibercept and dexamethasone implant on serous retinal detachment in the treatment of naive diabetic macular edema.
Bolukbasi S; Cakir A; Erden B; Karaca G
Cutan Ocul Toxicol; 2019 Dec; 38(4):401-405. PubMed ID: 31438736
[No Abstract] [Full Text] [Related]
[Next] [New Search]
